Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Carpenter

Showing results (241-250 of 254) with videos related to

Pageof 26
Sort By:
Transplantation Proceedings|February 1, 1987
Anti-T12 monoclonal antibody therapy of acute renal allograft rejectionE L Milford, C B Carpenter, R L Kirkman, et al.
Annals of Internal Medicine|September 1, 1983
Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunctionS Srikanta, O P Ganda, R A Jackson, et al.
Transplantation Proceedings|February 1, 1987
Monoclonal anti-IL-2 receptor antibody in primate renal transplantationM E Shapiro, R L Kirkman, M H Reed, et al.
Nature Medicine|February 2, 2000
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodiesJ R Mascola, G Stiegler, T C VanCott, et al.
Transplantation|September 1, 1989
Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibodyE L Ramos, E L Milford, R L Kirkman, et al.
Transplantation Proceedings|February 1, 1991
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantationR L Kirkman, M E Shapiro, C B Carpenter, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1975
The effects of varying dialysis regimens on lymphocyte stimulationK S Hurst, L F Saldanha, S M Steinberg, et al.
Transplantation Proceedings|December 1, 1988
A further analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus immune globulin: interim comparison of a randomized and an open-label trialD R Snydman, B G Werner, N L Tilney, et al.
Transplantation|January 1, 1989
Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibodyM H Reed, M E Shapiro, T B Strom, et al.
Transplantation Proceedings|February 11, 1991
Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trialsD R Snydman, B G Werner, N L Tilney, et al.
Pageof 26

Showing results (241-250 of 254) with videos related to

Sort By:
Pageof 26
Transplantation Proceedings|February 1, 1987
Anti-T12 monoclonal antibody therapy of acute renal allograft rejectionE L Milford, C B Carpenter, R L Kirkman, et al.
Annals of Internal Medicine|September 1, 1983
Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunctionS Srikanta, O P Ganda, R A Jackson, et al.
Transplantation Proceedings|February 1, 1987
Monoclonal anti-IL-2 receptor antibody in primate renal transplantationM E Shapiro, R L Kirkman, M H Reed, et al.
Nature Medicine|February 2, 2000
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodiesJ R Mascola, G Stiegler, T C VanCott, et al.
Transplantation|September 1, 1989
Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibodyE L Ramos, E L Milford, R L Kirkman, et al.
Transplantation Proceedings|February 1, 1991
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantationR L Kirkman, M E Shapiro, C B Carpenter, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1975
The effects of varying dialysis regimens on lymphocyte stimulationK S Hurst, L F Saldanha, S M Steinberg, et al.
Transplantation Proceedings|December 1, 1988
A further analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus immune globulin: interim comparison of a randomized and an open-label trialD R Snydman, B G Werner, N L Tilney, et al.
Transplantation|January 1, 1989
Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibodyM H Reed, M E Shapiro, T B Strom, et al.
Transplantation Proceedings|February 11, 1991
Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trialsD R Snydman, B G Werner, N L Tilney, et al.
Pageof 26